Proprietary biosynthesis process to produce cannabinoids
Provisional patent application filed
Cost-effective methodology to produce trace cannabinoids
If you have any doubt that InMed Pharm… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has retained the consulting services of Ben Paterson, P.E., t… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has been included in the CSE25 Index after qualifying as one… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning provided an update to its investors on the significant advancements in the deve… Read More
Provisional patent application protects unique process yielding pharmaceutical grade, bio-identical cannabinoids
Proprietary research allows production of synthetic cannabinoids for therape… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the filing of a provisional patent application in the United States f… Read More
Forbes predicts medical marijuana sales to reach $13.3 billion by 2020
Biotech/pharma market could surpass $20 billion by 2020, per estimates from Viridian Capital Advisors
InMed’s bi… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced the addition of Dr. Mauro Maccarrone to its scientific advisory board… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced preclinical results in the development of INM-405 for the treatment o… Read More
Biosynthesis technology making strong advances
Two promising pipeline candidates
Inclusion in the CSE25 Index
InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues down the fast tr… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced results from a study co-sponsored by InMed and the University of Brit… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) continues to advance its drug development programs through the use of its proprietary bioinf… Read More
InMed Pharmaceuticals (CSE: IN) (OTCQB: IMLFF) this morning said that it will be presenting twice at the Biopharma Forum on ‘Cannabis-Based Science & Medicine’ conference. T… Read More
Pre-clinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) was recently highlighted in a company spotlight article by Visual Capitalist. The article f… Read More
Horizons ETFs Management (Canada) Inc. recently announced completion of its quarterly rebalance of the constituent holdings of the Horizons Marijuana Life Sciences Index ETF (“HMMJ&rd… Read More
Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced that it has closed its previously detailed non-brokered private place… Read More
InMed Pharmaceuticals Inc., located in Vancouver, British Columbia, is a biopharmaceutical company engaged in the discovery and development of novel, cannabinoid-based therapeutics for the t… Read More
geralt / Pixabay
President Trump released from hospital after COVID-19 diagnosis; doctors add steroid used in treating more severe patients.
President Trump, eager to demonstrate that his co… Read More
Big Market Research: “Global Hydromassage Showers Market” report is an overview of the market is provided with prime focus on factors boosting and debilitating market. This will… Read More
Medical technology company GE Healthcare has selected six Indian startups under its 'Cohort 3' programme to help them build and scale up their technologies for their target market segments.T… Read More
First-ever Grand Prize, Growth Grant and Seed Grant winners selected for innovative solutions that will transform the food system and improve sustainability
CHICAGO–(BUSINESS WIRE)… Read More
InMed Pharmaceuticals GAAP EPS of -$4.06, revenue of $0.32M
This News InMed Pharmaceuticals GAAP EPS of -$4.06, revenue of $0.32M appeared first on STL.News Read More
Wellbeing Nutrition raises $10M in Series B from HUL and Fireside Ventures Wellbeing Nutrition, a science-backed, all-natural direct-to-consumer (D2C) nutrition company… Read More
"Medical Infrared lamps Market Trends Analysis Report 2023-2029:The Medical Infrared lamps Market report provides information about the Global industry, including valuable facts and figures… Read More
Research Nester published a report titled “Gait Rehabilitation System Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers a detailed overview… Read More
(TrendHunter.com) The conceptual ‘Inmed' medical kickscooter is a piece of transportation equipment for first responders to help them get to the scene of an accident or medical eme… Read More
InMed’s Rare Cannabinoid Production May Offer Potent Health Benefits The human body naturally produces cannabinoids – endocannabinoids such as anandamide (“ANA”) &nda… Read More
CanninBot Signal Alert: InMed Pharma Soars 50% Today, CanninBot recognized a BUY signal for InMed Pharma (Nasdaq: INM) which subsequently soars over 50% on the day. But why did InMed stock s… Read More
The latest report from Market.Biz researchers examines the Hospital Bed Head Unit market. It covers all the important aspects. The report covers everything from macro view of Hospital Bed He… Read More
The latest report from Market.Biz researchers examines the Hospital Bed Head Unit market. It covers all the important aspects. The report covers everything from macro view of Hospital Bed He… Read More
According to Future Market Insights, global Dystrophic Epidermolysis Bullosa Management is expected to grow at a CAGR of 5.7% between 2023 and 2033, reaching US$ 787.8 Million in 2033. With… Read More
Bharat Book Bureau Provides the Trending Market Research Report on “Global Bed Head Units (BHU) Market 2023-2029”under Life Sciences Market Research Report Category. The report o… Read More
"Hospital Bed Head Unit Market Overview by Trends 2023-2030The Hospital Bed Head Unit market report provides a comprehensive analysis of the global industry. The report includes valuable inf… Read More
A comprehensive research report on the Global Nerve Stimulators Market is a focused research compilation of all factors that can be considered critical for the evaluation of any business. Th… Read More
Research Nester published a report titled “Cardiometabolic Drugs Market: Global Demand Analysis & Opportunity Outlook 2031” which delivers a detailed overview of th… Read More
Research Nester published a report titled “Cannabinoid Biosynthesis Market: Global Demand Analysis & Opportunity Outlook 2035” which delivers a detailed overview of… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced f… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represent… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, will be represent… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids, today announced that results from a neuro… Read More
Cardiometabolic Drugs Market report which delivers a detailed overview of the global cardiometabolic drug marketin terms of market segmentation by drug type, disease, distribution channel, a… Read More
This report studies the Constant Temperature Wax Therapy Device Market with many aspects of the industry like the market size, market status, market trends and forecast, the repo… Read More
Cannabinoid Biosynthesis Market report which delivers a detailed overview of the global cannabinoid biosynthesis marketin terms of market segmentation by type, application, and by region. Fu… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced s… Read More
$2.3M revenues (unaudited) in Q4 2023, representing 123% increase quarter over quarter ("QoQ") Optimized and scaled up manufacturing processes over the last 12 months to meet increasing dema… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today provided a… Read More
Vancouver, British Columbia--(Newsfile Corp. - July 21, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development, man… Read More
InMed Pharmaceuticals (NASDAQ: INM) is a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs. The company tod… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing, and commercialization of rare cannabinoids and cannabinoid analogs, today announced… Read More
Vancouver, British Columbia--(Newsfile Corp. - September 22, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, development… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, is reporting on t… Read More
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development, manufacturing and commercialization of rare cannabinoids and cannabinoid analogs, today announced i… Read More
Vancouver, British Columbia--(Newsfile Corp. - October 24, 2023) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a leader in the pharmaceutical research, developm… Read More